Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

GANFORT EYE DROPS [SIN13589P]

Active ingredients: BIMATOPROST | TIMOLOL MALEATE 6.8 MG/ML EQV. TO TIMOLOL BASE

View product's general information
Last updated on 9 October 2026

Product Info

GANFORT EYE DROPS

[SIN13589P]

Product information

Active Ingredient and Strength

BIMATOPROST - 0.3 MG/ML
TIMOLOL MALEATE 6.8 MG/ML EQV. TO TIMOLOL BASE - 5 MG/ML

Dosage Form

SOLUTION, STERILE

Manufacturer and Country

ALLERGAN PHARMACEUTICALS IRELAND - IRELAND

Registration Number

SIN13589P

Licence Holder

ABBVIE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

S01ED51

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

INDICATIONS AND USAGE

Reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

Dosing

DOSAGE AND ADMINISTRATION

Recommended dosage in adults (including the elderly)

The recommended dose is one drop of GANFORT® in the affected eye(s) once daily, administered either in the morning or in the evening. It should be administered at the same time each day.

Existing literature data for GANFORT® suggest that evening dosing may be more effective in IOP lowering than morning dosing. However, consideration should be given to the likelihood of compliance when considering either morning or evening dosing.

If one dose is missed, treatment should continue with the next dose as planned. The dose should not exceed one drop in the affected eye(s) daily.

If more than one topical ophthalmic product is to be used, the different products should be instilled at least 5 minutes apart.

Use in renal and hepatic impairment

GANFORT® has not been studied in patients with hepatic or renal impairment. Therefore caution should be used in treating such patients.

Use in children and adolescents

GANFORT® has only been studied in adults and therefore its use is not recommended in children or adolescents.

Contraindications

CONTRAINDICATIONS

  • Hypersensitivity to the active substances or to any of the excipients.

  • Reactive airway disease including bronchial asthma or a history of bronchial asthma, severe chronic obstructive pulmonary disease.

  • Sinus bradycardia, sick sinus syndrome, sino-atrial nodal block, second or third degree atrioventricular block not controlled with a pacemaker; overt cardiac failure, cardiogenic shock.